Articles » Aspergillosis: DBMD

Aspergillosis: DBMD

Article title: Aspergillosis: DBMD

Conditions: Aspergillosis

Source: DBMD

---

Aspergillosis

   

Clinical Features	In immunosuppressed hosts: invasive pulmonary infection, usually with fever, cough, and chest pain. May disseminate to other organs, including brain, skin and bone. In immunocompetent hosts: localized pulmonary infection in persons with underlying lung disease. Also causes allergic sinusitis and allergic bronchopulmonary disease.
Etiologic Agent	Aspergillus fumigatus, A. flavus. Less commonly A. terreus, A. nidulans, A. niger.
Reservoir	Ubiquitous in the environment. Found in soil, decomposing plant matter, household dust, building materials, ornamental plants, items of food, and water.
Incidence	Not reportable. Population-based data available for San Francisco suggest a rate of 1-2 per 100,000 per year.
Sequelae	If severe granulocytopenia persists, mortality rate can be very high (up to 100% in patients with cerebral abscesses). Patient outcome depends on resolution of granulocytopenia and early institution of effective antifungal drug therapy.
Transmission	Inhalation of airborne conidia (spores). Nosocomial infection may be associated with dust exposure during building renovation or construction. Occasional outbreaks of cutaneous infection traced to contaminated biomedical devices.
Risk Groups	Persons with severe, prolonged granulocytopenia (e.g., hematologic malignancy, hematopoietic stem cell and solid organ transplant recipients, and patients on high-dose corticosteroids). Rarely, persons with HIV infection.
Surveillance	No national surveillance exists. Active surveillance is being conducted among hematopoietic stem cell and solid organ transplant recipients in selected U.S. hospitals.
Challenges	Identifying modifiable risk factors for disease in immunocompromised persons. Improving understanding of sources and routes of transmission from the environment. Developing sensitive and specific methods for earlier diagnosis.
Opportunities	Development of rapid antigenemia and antigenuria tests and molecular probes may facilitate earlier clinical diagnosis. Availability of improved molecular typing methods may assist in epidemiologic studies.
	December 2001

 
 
 

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Research
mistakes, errors,
and misdiagnosis
of major diseases.

Check one
or many
symptoms